LianBio (LIAN) Competitors $0.29 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends LIAN vs. AFMD, OMGA, RANI, NVCT, INMB, ANVS, PDSB, ANIX, BNTC, and MEShould you be buying LianBio stock or one of its competitors? The main competitors of LianBio include Affimed (AFMD), Omega Therapeutics (OMGA), Rani Therapeutics (RANI), Nuvectis Pharma (NVCT), INmune Bio (INMB), Annovis Bio (ANVS), PDS Biotechnology (PDSB), Anixa Biosciences (ANIX), Benitec Biopharma (BNTC), and 23andMe (ME). These companies are all part of the "pharmaceutical products" industry. LianBio vs. Affimed Omega Therapeutics Rani Therapeutics Nuvectis Pharma INmune Bio Annovis Bio PDS Biotechnology Anixa Biosciences Benitec Biopharma 23andMe LianBio (NASDAQ:LIAN) and Affimed (NASDAQ:AFMD) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, risk, analyst recommendations, profitability, institutional ownership, dividends, community ranking and earnings. Which has stronger valuation and earnings, LIAN or AFMD? LianBio has higher earnings, but lower revenue than Affimed. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLianBioN/AN/A-$110.29M-$0.81-0.36Affimed$8.95M5.56-$114.66MN/AN/A Do analysts rate LIAN or AFMD? LianBio presently has a consensus target price of $3.50, indicating a potential upside of 1,106.48%. Affimed has a consensus target price of $20.00, indicating a potential upside of 513.50%. Given LianBio's higher probable upside, analysts plainly believe LianBio is more favorable than Affimed.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LianBio 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50Affimed 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility and risk, LIAN or AFMD? LianBio has a beta of 0.23, meaning that its stock price is 77% less volatile than the S&P 500. Comparatively, Affimed has a beta of 2.1, meaning that its stock price is 110% more volatile than the S&P 500. Is LIAN or AFMD more profitable? LianBio has a net margin of 0.00% compared to Affimed's net margin of -2,922.74%. LianBio's return on equity of -33.17% beat Affimed's return on equity.Company Net Margins Return on Equity Return on Assets LianBioN/A -33.17% -30.19% Affimed -2,922.74%-155.30%-92.65% Do insiders & institutionals believe in LIAN or AFMD? 74.8% of LianBio shares are owned by institutional investors. Comparatively, 30.8% of Affimed shares are owned by institutional investors. 7.6% of LianBio shares are owned by company insiders. Comparatively, 3.8% of Affimed shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media prefer LIAN or AFMD? In the previous week, Affimed had 1 more articles in the media than LianBio. MarketBeat recorded 1 mentions for Affimed and 0 mentions for LianBio. Affimed's average media sentiment score of 0.67 beat LianBio's score of 0.00 indicating that Affimed is being referred to more favorably in the news media. Company Overall Sentiment LianBio Neutral Affimed Positive Does the MarketBeat Community favor LIAN or AFMD? Affimed received 431 more outperform votes than LianBio when rated by MarketBeat users. Likewise, 70.16% of users gave Affimed an outperform vote while only 36.36% of users gave LianBio an outperform vote. CompanyUnderperformOutperformLianBioOutperform Votes436.36% Underperform Votes763.64% AffimedOutperform Votes43570.16% Underperform Votes18529.84% SummaryAffimed beats LianBio on 8 of the 15 factors compared between the two stocks. Ad Crypto 101 MediaThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech giants are quietly integrating it. Venture capitalists are scrambling to invest.Click here to discover our #1 crypto for the market right now – poised for massive growth Get LianBio News Delivered to You Automatically Sign up to receive the latest news and ratings for LIAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIAN vs. The Competition Export to ExcelMetricLianBioBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$31.35M$202.91M$5.02B$8.42BDividend YieldN/A3.48%7.52%4.16%P/E Ratio-0.36337.76128.8716.66Price / SalesN/A21,765.411,725.1179.42Price / CashN/A11.0836.9133.53Price / Book0.116.874.595.19Net Income-$110.29M-$19.89M$114.09M$223.67M7 Day Performance3.61%-0.17%110.38%2.63%1 Month Performance-0.38%2.70%124.28%8.69%1 Year Performance-92.80%24.25%154.70%28.41% LianBio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIANLianBio1.1771 of 5 stars$0.29flat$3.50+1,106.5%-92.8%$31.35MN/A-0.36110Gap UpAFMDAffimed3.6187 of 5 stars$3.26+0.9%$20.00+513.5%-10.6%$49.64M$2.68M0.0076Positive NewsOMGAOmega Therapeutics1.7001 of 5 stars$1.11-4.3%$10.20+818.9%-38.7%$61.22M$3.09M-0.78120RANIRani Therapeutics3.0337 of 5 stars$2.31+0.9%$11.71+407.1%+17.9%$122.30M$2.72M-1.96110Positive NewsNVCTNuvectis Pharma1.8117 of 5 stars$6.41-14.2%$21.00+227.6%-32.9%$119.55MN/A-4.978Gap UpHigh Trading VolumeINMBINmune Bio2.3045 of 5 stars$6.04+3.2%$20.00+231.1%-16.3%$119.35M$160,000.00-2.9310Earnings ReportANVSAnnovis Bio2.1597 of 5 stars$9.09-2.0%$32.17+253.9%+43.4%$118.62MN/A-1.783PDSBPDS Biotechnology0.9578 of 5 stars$3.20+0.3%$14.25+345.3%-29.7%$117.82MN/A-2.6220Analyst UpgradeANIXAnixa Biosciences2.5366 of 5 stars$3.66+4.6%$7.00+91.3%+13.7%$117.78M$210,000.00-9.385BNTCBenitec Biopharma2.9963 of 5 stars$10.92+3.9%$22.60+107.0%+182.9%$115.27M$80,000.000.0020Upcoming EarningsME23andMe1.833 of 5 stars$4.65flat$9.40+102.2%-75.0%$113.97M$219.64M-0.18770 Related Companies and Tools Related Companies AFMD Alternatives OMGA Alternatives RANI Alternatives NVCT Alternatives INMB Alternatives ANVS Alternatives PDSB Alternatives ANIX Alternatives BNTC Alternatives ME Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LIAN) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LianBio Please log in to your account or sign up in order to add this asset to your watchlist. Share LianBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
